Roberto Cuca
Director of Finance/CFO at TELA BIO, INC.
Net worth: 509 535 $ as of 2024-03-30
Profile
Roberto E.
Cuca is currently the Chief Financial Officer & Operating Officer at TELA Bio, Inc. Prior to his current position, he held various roles including Director-Corporate & Business Development at moksha8 Pharmaceuticals, Inc. from 2008 to 2010, Treasurer & Senior Vice President-Finance at Endo Health Solutions, Inc. from 2010 to 2013, Chief Financial Officer at OraSure Technologies, Inc. from 2018 to 2021, and Chief Financial Officer & Senior Vice President at Trevena, Inc. from 2014 to 2018.
He also worked as a Research Analyst at JPMorgan Securities LLC.
Mr. Cuca received his undergraduate degree from Princeton University, an MBA from The Wharton School of the University of Pennsylvania, and a graduate degree from Cornell Law School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TELA BIO, INC.
0.36% | 2024-02-22 | 89,865 ( 0.36% ) | 509 535 $ | 2024-03-30 |
Roberto Cuca active positions
| Companies | Position | Start |
|---|---|---|
| TELA BIO, INC. | Director of Finance/CFO | 2021-09-26 |
Former positions of Roberto Cuca
| Companies | Position | End |
|---|---|---|
| ORASURE TECHNOLOGIES, INC. | Director of Finance/CFO | 2021-09-16 |
| TREVENA, INC. | Director of Finance/CFO | 2018-05-02 |
Endo Health Solutions, Inc.
 Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Director of Finance/CFO | 2013-07-31 |
moksha8 Pharmaceuticals, Inc.
 moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Corporate Officer/Principal | 2010-01-31 |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Analyst-Equity | 2008-05-30 |
Training of Roberto Cuca
| Princeton University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Cornell Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ORASURE TECHNOLOGIES, INC. | Health Technology |
| TELA BIO, INC. | Health Technology |
| TREVENA, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Endo Health Solutions, Inc.
Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Health Technology |
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
moksha8 Pharmaceuticals, Inc.
moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Health Technology |
- Stock Market
- Insiders
- Roberto Cuca
